FTC Challenges Illumina’s Proposed Acquisition Of “Nascent Competitive Threat” Pacific Biosciences

STAT (12/17, Herper) reports the FTC is challenging Illumina’s proposed $1.2 billion acquisition of Pacific Biosciences. The agency claims that the deal “would eliminate ‘a nascent competitive threat’ to Illumina’s monopoly in deciphering genetic material...